why am i so nauseous on tirzepatide GLP-1 nausea: How to handle GLP-1s' most How to prevent nausea when

Nevertheless, insulin remains the ideal treatment for patients who are pregnant or are planning to become pregnant, mainly because of the lack of evidence for the safety of other ADMs during this period

Sherin lives in Irving with her husband and loves spending her free time traveling around the world with family and friends

Ask your doctor to explain the specific clinical reasoning behind the refusal

Gentle movement like walking or yoga improves digestion and can ease stomach discomfort without overexertion

Long-term considerations Maintenance dosing After reaching goal weight: Some continue at therapeutic dose indefinitely Others may reduce to lower maintenance dose (4-8 mg) Weight regain is common if medication is stopped Long-term studies are ongoing Duration of treatment Based on clinical trial data: Weight loss continues for at least 48-68 weeks Plateau may not occur even at 48 weeks Long-term (multi-year) data not yet available Treatment may be indefinite for weight maintenance Monitoring recommendations Regular check-ins should include: Weight and body composition Blood pressure and heart rate Blood glucose and HbA1c Lipid panel Liver and kidney function Review of symptoms and side effects Frequently asked questions What is the starting dose for retatrutide

Gastrointestinal side effects are the most commonly reported and include: Nausea affects a significant proportion of patients, particularly during dose escalation Diarrhoea may be mild to moderate and usually improves with time Vomiting less common than nausea but can occur, especially at higher doses Constipation some patients experience reduced bowel movements Abdominal pain or discomfort typically mild but should be monitored Reduced appetite contributes to weight loss but may be excessive in some individuals These gastrointestinal symptoms are generally most pronounced when initiating treatment or increasing the dose